CGC Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

CGC Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.4K	Hold	913	–	–	﹤0.01%	195
2026 Q1	$19.9K	Hold	913	–	–	0.01%	172
2025 Q4	$19.6K	Hold	913	–	–	0.01%	186
2025 Q3	$17.6K	Hold	913	–	–	﹤0.01%	190
2025 Q2	$15.6K	Hold	913	–	–	0.01%	187
2025 Q1	$58.3K	Hold	913	–	–	0.02%	104
2024 Q4	$111K	Hold	913	–	–	0.04%	74
2024 Q3	$114K	Hold	913	–	–	0.05%	68
2024 Q2	$144K	Hold	913	–	–	0.06%	56
2024 Q1	$118K	Hold	913	–	–	0.06%	67
2023 Q4	$88K	Hold	913	–	–	0.04%	81
2023 Q3	$111K	Hold	913	–	–	0.08%	60
2023 Q2	$105K	Buy	+913	New	+$118K	0.07%	64

Other funds holding SRPT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

CGC Financial Services's SRPT Position: Q2 2026 in Review

CGC Financial Services held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 913 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #195.

CGC Financial Services first reported a position in SRPT in Q2 2023 and has held it in 13 quarters since. The position peaked at $144K in Q2 2024. 28 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

CGC Financial Services held 913 shares of Sarepta Therapeutics worth $16.4K as of Q2 2026.
CGC Financial Services left its Sarepta Therapeutics share count unchanged in Q2 2026.
Sarepta Therapeutics made up ﹤0.01% of CGC Financial Services's portfolio in Q2 2026, its #195 holding.
CGC Financial Services first reported a position in Sarepta Therapeutics in Q2 2023 and has held it in 13 quarters since.
CGC Financial Services's Sarepta Therapeutics position peaked at $144K in Q2 2024.
28 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on CGC Financial Services's 13F filing for Q2 2026, filed 13 Jul 2026.